Qingxin L. Yu

State Key Laboratory Of Complex Severe And Rare Disease, Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Macrophage-associated immune-stromal crosstalks correlate with the tumor microenvironment in microsatellite-stable mucinous colorectal cancer.

Macrophage-associated immune-stromal crosstalks correlate with the tumor microenvironment in microsatellite-stable mucinous colorectal cancer.

Journal: Pathology, research and practice

Published: November 06, 2025

Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications.

Harnessing Ribonucleoprotein Granule Biology for Cancer Therapy: The Central Role of Protein Modifications.

Journal: Research (Washington, D.C.)

Published: October 26, 2025

Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation.

Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation.

Journal: Materials today. Bio

Published: March 06, 2025

Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker.

Comprehensive pan-cancer analysis identifies PLAG1 as a key regulator of tumor immune microenvironment and prognostic biomarker.

Journal: Frontiers in immunology

Published: February 06, 2025

Interactions between radiotherapy resistance mechanisms and the tumor microenvironment.

Interactions between radiotherapy resistance mechanisms and the tumor microenvironment.

Journal: Critical reviews in oncology/hematology

Published: January 31, 2025

Decoding the crossroads of aging and cancer through single-cell analysis: Implications for precision oncology.

Decoding the crossroads of aging and cancer through single-cell analysis: Implications for precision oncology.

Journal: International journal of cancer

Published: November 29, 2024

Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistance.

Novel hormone therapies for advanced prostate cancer: Understanding and countering drug resistance.

Journal: Journal of pharmaceutical analysis

Published: November 19, 2024

Next-Generation Surgery: Integrating Artificial Intelligence, Genetic Technologies, Bioengineering and Rehabilitation Into Modern Practices.

Next-Generation Surgery: Integrating Artificial Intelligence, Genetic Technologies, Bioengineering and Rehabilitation Into Modern Practices.

Journal: Exploration (Beijing, China)

Published: November 13, 2024

SLC39A14 promotes the development of esophageal squamous cell carcinoma through PI3K/Akt/mTOR signaling pathway.

SLC39A14 promotes the development of esophageal squamous cell carcinoma through PI3K/Akt/mTOR signaling pathway.

Journal: International immunopharmacology

Published: October 12, 2024

Advancements and challenges of R-loops in cancers: Biological insights and future directions.

Advancements and challenges of R-loops in cancers: Biological insights and future directions.

Journal: Cancer letters

Published: October 08, 2024

Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedside.

Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedside.

Journal: Metabolism: clinical and experimental

Published: October 01, 2024

Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.

Microbiota and urinary tumor immunity: Mechanisms, therapeutic implications, and future perspectives.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: September 27, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026